氯胺酮用于机械通气成人镇痛镇静:双盲随机试验
该研究为前瞻性、双盲、随机、安慰剂对照试验,在澳大利亚墨尔本两家大学附属ICU开展,纳入接受机械通气并同时使用阿片类药物输注镇痛镇静的成人患者(排除心脏外科患者)。患者随机接受低剂量氯胺酮输注(0.15 mg/kg/hr)或安慰剂。主要终点为每小时阿片类药物剂量,氯胺酮组中位每小时阿片类药物剂量(芬太尼等效)为64 µg/hr(36-89 µg/hr),安慰剂组为77 µg/hr(47-100 µg/hr),中位差值为-13.0(95%可信区间-26.6至2.4),获益概率95.1%。大多数次要结局包括谵妄和显著不良事件两组间无差异。作者结论认为低剂量氯胺酮似乎安全并与每小时阿片类药物需求量减少相关,需更大规模随机对照试验评估其他以患者为中心的结局。
要点
- 在机械通气成人中,低剂量氯胺酮输注(0.15 mg/kg/hr)组每小时阿片类药物剂量(芬太尼等效)中位数为64 µg/hr(36-89 µg/hr),安慰剂组为77 µg/hr(47-100 µg/hr),中位差值-13.0(95%可信区间-26.6至2.4),获益概率95.1%。
- 两组在谵妄和显著不良事件等大多数次要结局上无差异。
- 作者结论认为低剂量氯胺酮似乎安全,并与每小时阿片类药物需求量减少相关。
- 作者指出需要更大规模随机对照试验评估对其他以患者为中心的结局的影响。
适用人群与场景
- 在ICU接受机械通气的成人患者,同时接受阿片类药物输注用于镇痛镇静。
- 排除心脏外科患者。
处置流程与药物剂量
- 低剂量氯胺酮输注:0.15 mg/kg/hr,在机械通气期间给药。
- 对照:安慰剂。
研究设计与关键结果
- 研究类型:前瞻性、双盲、随机、安慰剂对照试验;在澳大利亚墨尔本两家大学附属ICU开展,时间为2022年9月至2024年12月;共筛查538例患者,413例因排除标准不合格,5例撤回知情同意,最终120例(氯胺酮组59例,安慰剂组61例)纳入主要分析。
- 主要终点:每小时阿片类药物剂量(芬太尼等效)中位数(四分位距)氯胺酮组为64 µg/hr(36-89 µg/hr),安慰剂组为77 µg/hr(47-100 µg/hr),中位差值-13.0(95%可信区间-26.6至2.4),获益概率95.1%。
- 次要终点:大多数次要结局包括谵妄和显著不良事件两组间无差异。
证据类型、等级与局限
- 证据类型:前瞻性、双盲、随机、安慰剂对照试验。
- 局限:作者指出需要更大规模随机对照试验评估对其他以患者为中心的结局的影响。
对床旁实践的改变
- 作者结论认为低剂量氯胺酮输注似乎安全,并与ICU机械通气患者每小时阿片类药物需求量减少相关。
- 作者指出需要更大规模随机对照试验评估对其他以患者为中心的结局的影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: The role of ketamine for analgosedation in the ICU remains unclear. This study aimed to assess the efficacy of low-dose ketamine infusion for adjunct analgosedation in adults receiving mechanical ventilation.
DESIGN: A prospective, double blind, randomized, placebo-controlled trial.
SETTING: The study was conducted at two university-affiliated ICUs in Melbourne, Australia, between September 2022 and December 2024.
PATIENTS: Adult patients receiving mechanical ventilation in the ICU who were also receiving opioid infusion for analgosedation (excluding cardiac surgical patients).
INTERVENTIONS: Patients were randomized to receive low-dose ketamine infusion (0.15 mg/kg/hr) or placebo during the period of mechanical ventilation.
MEASUREMENTS AND MAIN RESULTS: The primary outcome was the hourly dose of opioids. Secondary outcomes included, among others, delirium, as well as ventilator, ICU, and hospital-free days to day 28. A total of 538 patients were screened for inclusion. Of these, 413 patients were ineligible based on exclusion criteria. A further five patients had consent withdrawn, leaving 120 patients (59 ketamine and 61 placebo) included for primary analysis. The median (interquartile range) hourly dose of opioids in fentanyl equivalents was 64 µg/hr (36-89 µg/hr) in the ketamine group and 77 µg/hr (47-100 µg/hr) in the placebo group (median difference, -13.0 [95% credible interval, -26.6 to 2.4]; probability of benefit, 95.1%). There were no differences between groups for most of the secondary outcomes, including delirium and significant adverse events.
CONCLUSIONS: Low-dose ketamine infusion appeared safe and was associated with a reduction in hourly opioid requirements in ICU patients receiving mechanical ventilation. Larger randomized controlled trials are required to assess effects on other patient-centered outcomes.
参考来源
- Casamento AJ, Ghosh AN, Said S, et al. Ketamine for Analgosedation in Mechanically Ventilated Adults: A Double-Blind Randomized Trial. Crit Care Med. 2026. PMID: 42704275. doi:10.1097/CCM.0000000000007341
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。